期刊文献+

双心房输注对二尖瓣置换术患者体外循环后肺动脉压的影响 被引量:4

Effects of biatrial infusion on pulmonary artery pressure after cardiopulmonary bypass in patients undergoing mitral valve replacement
原文传递
导出
摘要 目的 评价双心房输注对二尖瓣置换术患者体外循环后肺动脉压(PAP)的影响.方法 择期行二尖瓣置换术合并肺动脉高压[平均肺动脉压(MPAP)>50 mm Hg]的患者20例,年龄22~53岁,体重34~57kg,心功能分级Ⅱ或Ⅲ级,随机分为2组(n=10):右心房输注组(R组)和双心房输注组(B组).麻醉诱导后右颈内静脉穿刺置入Swan-Ganz三腔漂浮导管,监测CVP、PAP、肺毛细血管楔压(PCWP)和CO.R组经中心静脉输注前列腺素E130~150 ng·kg-1·min-1和去氧肾上腺素0.2~0.6μg·kg-1·min-1.B组经中心静脉输注前列腺素E130~150 ng·kg·min-1,经左心房输注去氧肾上腺素0.2~0.6μg·kg-1·min-1.分别于给药前5 min(T0)、给药后5 min(T1)、10 min(T2)、30 min(T3)和60 min(T4)时记录MAP、HR、MPAP、PCWP、CVP和CO,计算肺血管阻力指数(PVRI)、体循环血管阻力指数(SVRI)和CI.结果 与T0时比较,R组T1-4时MAP、MPAP、PCWP和PVRI降低,CI升高(P<0.05),HR、CVP和SVRI差异无统计学意义(P>0.05),B组T1-4时MAP、CI和SVRI升高,HR、MPAP、PCWP、CVP和PVRI降低(P<0.05);与R组比较,B组MAP、CI和SVRI升高,HR、MPAP、PCWP、PVRI和CVP降低(P<0.05).结论 双心房输注可降低二尖瓣置换术患者体外循环后肺动脉压和肺血管阻力. Objective To investigate the effects of biatrial infusion on pulmonary artery pressure (PAP)after cardiopulmonary bypass (CPB) in patients undergoing mitral valve replacement.Methods Twenty NYHA Ⅱ or Ⅲ patients aged 22-53 yr weighing 34-57 kg undergoing mitral valve replacement complicated by pulmonary hypertension (mean pulmonary artery pressure (MPAP) > 50 mm Hg) were randomly divided into 2 groups ( n = 10 each): infusion via right atrium group (group R) and infusion via both atria group (group B). After induction of anesthesia, a three cavity floating Swan-Ganz catheter was placed via right internal jugular vein to monitor CVP,PAP, pulmonary capillary wedge pressure (PCWP) and CO. The patients received infusion of prostaglandin E1 30-150 ng· kg- 1 · min - 1 and phenylephrine 0.2-0.6 μg· kg- 1 · min- 1 via central veins in group R and infusion of prostaglandin E1 30-150 ng·kg-1 ·min-1 via central veins and phenylephrine 0.2-0.6 μg·kg-1 ·min-1 via left atrium in group B. MAP, HR, MPAP, PCWP, CVP and CO were recorded 5 min before administration (T0), and 5,10, 30 and 60 min after administration (T1-4). Pulmonary vascular resistance index (PVRI), systemic vascular resistance index (SVRI) and CI were also calculated. Results D:/1111111111/MDB/zhmzxzz98201008.mdbCompared with the value at T0, MAP, MPAP, PCWP and PVRI were significantly decreased, while CI was increased at T1-4 in group R, and MAP, CI and SVRI were significantly increased, while HR, MPAP, PCWP, CVP and PVRI decreased at T1-4 in group B ( P < 0.05).MAP, CI and SVRI were significantly higher, while HR, MPAP, PCWP, PVRI and CVP lower in group B than in group R ( P < 0.05). Conclusion Biatrial infusion can effectively reduce PAP and pulmonary vascular resistance after CPB in patients undergoing mitral valve replacement.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2010年第8期950-952,共3页 Chinese Journal of Anesthesiology
基金 江西省卫生厅资助项目(050291)
关键词 高血压 肺性 心肺转流术 双心房输注 Hypertension, pulmonary Cardiopulmonary bypass Biatrial infusion
作者简介 通信作者:王风芝,Email:fengzhiwang50@sina.com
  • 相关文献

参考文献3

二级参考文献11

  • 1姚永兴,姜桢.肺-体循环分别给药救治体外循环停机困难一例[J].中华医学杂志,2006,86(41):2947-2949. 被引量:1
  • 2胡小琴.心血管麻醉与体外循环[M].人民卫生出版社,1997.282.
  • 3Hopkins RA, Bull C, Haworth SG, et al. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg, 1991, 5:628-634.
  • 4Reich DL, Bodian CA, Krol M, et al. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg, 1999, 89:814-822.
  • 5Tritapepe L, Voci P, Cogliati AA, et al. Successful weaning from cardiopuhnonary bypass with central venous prostaglandin El and left atrial norepinephrine infusion in patients with acute pulmonary hypertension. Crit Care Med, 1999, 27:2180-2183.
  • 6Fischer LG, Van Aken H, Burkle H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg, 2003, 96: 1603-1616.
  • 7Aral A, Oguz M, Ozberrak H, et al. Hemodynamic advantages of left atrial epinephrine administration in open heart operations. Ann Thorac Surg, 1997, 64:1046-1049.
  • 8Aranda M, Bradford KK, Pearl RG. Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental puhnonary hypertension. Anesth Analg, 1999. 89,152-158.
  • 9D' Ambra MN, Laraia PJ, Philbin DM, et al. Prostaglandin E1 : a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg, 1985, 89:567-572.
  • 10姜桢,金翔华,陈伟,叶磊.NO用于瓣膜置换患者围术期效应的观察[J].医学理论与实践,1999,12(6):313-316. 被引量:1

共引文献8

同被引文献15

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部